Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 90 member A23 (FAM90A23) is annotated as a protein-coding gene but is also frequently described as a pseudogene or a putative protein, reflecting uncertainty about whether it produces a functional protein in vivo[1][5][6]. It is a member of the primate-specific FAM90A gene family, which has arisen through multiple duplications and rearrangements, largely in primates[2]. There is no compelling evidence that this gene or its product (if expressed) acts as a functional receptor, enzyme, or other classical therapeutic target, and there are no validated biological roles, disease associations, or known drugs or biomarkers associated with FAM90A23[1][5][6]. Its main status in the literature is as a gene of unknown or putative function, likely related to roles in gene regulation typical of certain pseudogenes[9]. Key notes: - FAM90A23 is sometimes listed in protein databases, but often under "pseudogene" classifications or with "putative" status, indicating unclear evidence for translation into a functional protein[1][6]. - There is no evidence linking it to established biological functions, pathologies, or drug interactions. - "Is_target" is set to false because it does not meet criteria for being considered a therapeutic target, and "is_incorrect" is true because this entry is either a pseudogene, has no established function, or is a mischaracterization as a drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 90 member A23 (FAM90A23).